AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimifos M2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Berlincleve Pharmaceuticals Llp

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimifos M2 Tablet PR

Duo-antidiabetic Glimifos M2 PR tablets manage type 2 diabetes in adults by combining two active ingredients. This medication helps regulate blood glucose. Always take it with food, consistently at the same time daily for optimal effect. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; abrupt cessation can lead to dangerously elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Commonly, Glimifos M2 PR can cause hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and trembling, and know how to treat them promptly. Maintain regular mealtimes and always carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Disclose any history of heart disease to your doctor before starting this treatment. Its suitability for pregnant or breastfeeding women requires prior medical consultation. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function as directed by your physician.

Primary Ingredients of Glimifos M2 Tablet PR

The information is unavailable.

Uses of Glimifos M2 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimifos M2 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Take Glimifos M2 Tablet PR with a meal.

Common Side effects of Glimifos M2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimifos M2 Tablet PR:

Follow your doctor's instructions or refer to the product label for proper administration. Take Glimifos M2 Tablet PR with a meal.

How Glimifos M2 Tablet PR works:

Glimifos M2 Tablet PR combines glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimifos M2 Tablet PR with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimifos M2 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

The medication Glimifos M2 Tablet PR is contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimifos M2 Tablet PR; dosage modification may be necessary. Consult your physician for guidance. Glimifos M2 Tablet PR is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimifos M2 Tablet PR cautiously, potentially requiring dose modification. Physician consultation is advised. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimifos M2 Tablet PR :

Should you forget a dose of Glimifos M2 Tablet PR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimifos M2 Tablet PR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimifos M2 Tablet PR

Store this medication in its original, tightly sealed container or packaging. Follow the storage instructions provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Glimifos M2 Tablet PR use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare but potentially harmful side effect of metformin is particularly concerning for individuals with pre-existing kidney problems, the elderly, or those who consume significant amounts of alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse. Should these symptoms appear, discontinue Glimifos M2 Tablet PR and seek immediate medical attention.
Glimifos M2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood sugar control when used alongside a healthy diet and regular physical activity. Glimepiride stimulates the pancreas to release more insulin, thereby reducing blood glucose. Metformin decreases glucose production in the liver and increases insulin effectiveness. This formulation is unsuitable for treating type 1 DM.
Glimifos M2 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Indeed, prolonged Glimifos M2 Tablet PR administration can lead to Vitamin B12 insufficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Left unaddressed, this deficiency may result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. Prophylactic Vitamin B12 supplementation, at least annually, is recommended by some experts to mitigate these risks.
Glimifos M2 Tablet PR can indeed lead to hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar may include nausea, headache, irritability, hunger pangs, sweating, lightheadedness, a rapid pulse, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concurrent use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available simple sugars, such as glucose tablets, honey, or fruit juice, is recommended.
Consuming alcohol concurrently with Glimifos M2 Tablet PR is unsafe due to the risk of significantly reduced blood sugar (hypoglycemia) and a heightened probability of lactic acidosis.
Glimifos M2 Tablet PR
68
MRP 83
18% off